- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07388134
Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain
Effects of Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain
One of the most prevalent causes of pain on a global scale is chronic musculoskeletal pain. Low back pain is a prevalent manifestation of chronic musculoskeletal pain.
There are a wide vary of no pharmacologic treatment for chronic pain. From a physiotherapy perspective, the chronic pain management should be oriented towards increasing the self-management of people with chronic pain. The management components in question are therapeutic exercise and education.
High-intensity interval training (HIIT) is a novel therapeutic exercise strategy that has been shown to reduce pain and disability in chronic low back pain. It is a hopeful strategy to enhance motivation to treatment. Pain neuroscience education (PNE) has also been demonstrated to enhance pain and disability in chronic low back pain. Finally, virtual reality (VR) has been demonstrated to be effective in the chronic low back pain management.
Despite the benefits mentioned in these three therapies being isolated, there are no studies that have compared VR-based HIIT (VR-HIIT) with PNE in chronic low back pain. The use of these interventions may increase the intervention benefits. The investigators hypothesise that VR-HIIT with PNE can reduce pain intensity, enhance fear of movement and improve motivation for treatment in chronic low back pain. Therefore, the aim of this study is to evaluate the effects of VR-HIIT with PNE in chronic low back pain.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Granada, Spain, 18016
- University of Granada
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults 18-65 years
- Chronic low back pain
- Pain intensity ≥ 3 points with the numeric pain rating scale
- Ability to walk ≥ 15 minutes
- Wish to participate in the study and sign the informed consent
Exclusion Criteria:
- Pregnancy
- Patients with severe comorbidities that interfere with the ability to perform the study
- People who are currently participating in another study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual reality-based high intensity interval training (VR-HIIT) group
|
A single session of 70-90 minutes.
|
|
Active Comparator: High intensity interval training (HIIT) group
|
A single session of 70-90 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: Baseline, during the intervention and 48-72 hours post-intervention
|
To assess pain intensity using the Numeric Pain Rating Scale.
Scores range from 0 (no pain) to 10 (worst pain imaginable).
Higher scores indicate greater intensity.
|
Baseline, during the intervention and 48-72 hours post-intervention
|
|
Pain pressure threshold
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess pain pressure threshold.
The measurement will be taken in the paravertebral and tibialis anterior muscles with the algometer Force One FPIX 50.
The measurement points will be lumbar region bilaterally 5 cm from the spinous processes of L3 and L5; and right tibialis anterior, 5 cm below the tibial tuberosity.
The assessor will place the algometer perpendicular and applied increasing pressure.
until the pressure became painful.
The mean of 3 measurements was recorded.
|
Baseline and 48-72 hours post-intervention
|
|
Pain modulation
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess pain modulation using algometer Force One FPIX 50.
The pressure pain threshold will be evaluated in the tibialis anterior muscle and the deltoid muscle.
Then the conditioning stimulus will be introduced.
A clamp will be placed on the earlobe for 60 seconds.
When pain VAS of the earlobe become more than 60 mm, pain pressure threshold will be evaluated again
|
Baseline and 48-72 hours post-intervention
|
|
Fear to movement
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess fear to movement using the TAMPA Scale of Kinesiophobia (TSK).
Scores range from 1 (totally disagree) to 4 (totally agree).
The final score can range between 11 and 44 points.
Higher scores indicate greater perceived fear of movement.
|
Baseline and 48-72 hours post-intervention
|
|
Catastrophizing of pain
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess catastrophizing of pain using the Pain Catastrophizing Scale (PCS).
Scores range from 0 (nothing at all) to 4 (all the time).
The final score range from 0 to 52.
Higher scores indicate greater levels of catastrophism
|
Baseline and 48-72 hours post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity and interference
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess pain intensity and interference using the Brief Pain Inventory (BPI).
Scores range from 0 (no pain/does not interfere) to 10 (worst pain imaginable/completely interferes).
Higher scores indicate greater intensity and interference.
|
Baseline and 48-72 hours post-intervention
|
|
Pain vigilance and awareness
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess awareness, consciousness, vigilance and observation of pain using the Pain Vigilance and Awareness Questionnaire (PVAQ).
Scores range from 0 (never) to 5 (always).
The total scores range between 0 and 80. Higher scores indicate greater awareness, consciousness, vigilance and observation of pain.
|
Baseline and 48-72 hours post-intervention
|
|
Pain beliefs
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess fear and avoidance beliefs using Fear and Avoidance Beliefs Questionnaire (FABQ).
Scores range from 0 (totally disagree) to 6 (totally agree).
The total score range from 0 to 96.
Higher scores indicate a higher degree of fear avoidance beliefs.
|
Baseline and 48-72 hours post-intervention
|
|
Health related quality of life
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess quality of life using the EuroQol-5D.
Total score range from 1 (best health status) to 0 (death).
The second part of the euroqol-5d is visual analogue scale that goes from 0 (worst state of health imaginable) to 100 (best state of health imaginable).
|
Baseline and 48-72 hours post-intervention
|
|
Pain self-efficacy
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess pain-self efficacy using 10 items Pain Self-Efficacy Questionnaire (10-PSEQ).
Scores range from 0 (not at all confident) and 6 (completely confident).
A total score range from 0 to 60. Higher scores reflect stronger self-efficacy beliefs.
|
Baseline and 48-72 hours post-intervention
|
|
Sleep quality
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess sleep quality using a numeric scale from 0 (worst sleep quality) to 10 (best sleep quality).
Higher scores indicate greater sleep quality
|
Baseline and 48-72 hours post-intervention
|
|
Disability
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess disability using the Oswestry Disability Index (ODI).
Total scores range from 0% (no limitation) to 100% (maximum functional limitation).
Higher scores indicate higher levels of disability.
|
Baseline and 48-72 hours post-intervention
|
|
Functional status
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess functional status using the Patient-Specific Functioning Scale (PSFS).
Scores range from 0 to 10. Higher scores indicating better functional status
|
Baseline and 48-72 hours post-intervention
|
|
Mobility
Time Frame: Baseline and 48-72 hours post-intervention
|
To assess mobility using the Fingertip-to-Floor test.
It will be used to examine the ability to bend forward while standing, measuring the distance between the tip of the longest finger and the floor.
Lower scores are associated with decreased symptoms across all outcome measures.
|
Baseline and 48-72 hours post-intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motivation for Treatment
Time Frame: Baseline
|
To assess motivation to treatment with the 15-item Treatment Self-Regulation Questionnaire (TSRQ).
Scores range from 1 to 7 per item.
Higher scores indicate greater motivation
|
Baseline
|
|
Adverse events
Time Frame: During the intervention
|
To measure the number of adverse events that may occur during the intervention.
|
During the intervention
|
|
Pain vigilance
Time Frame: During the intervention
|
To assess pain vigilance during the intervention with a numeric scale from 0 (none) to 10 (continuously).
|
During the intervention
|
|
Treatment-Generated motivation
Time Frame: 48-72 hours post-intervention
|
To assess treatment-generated motivation with the 22-item Intrinsic Motivation Inventory (IMI).
Scores range from 1 to 7 per item.
Higher scores indicate greater motivation
|
48-72 hours post-intervention
|
|
Satisfaction with the intervention
Time Frame: 48-72 hours post-intervention
|
To assess satisfaction with the intervention with numeric scale from 0 (no satisfaction) to 10 (completely satisfaction).
Higer scores indicate higher levels of satisfaction.
|
48-72 hours post-intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIIT_DLC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Low-back Pain (cLBP)
-
Lahore University of Biological and Applied SciencesRecruitingChronic Low-back Pain (cLBP)Pakistan
-
University of WashingtonNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingChronic Low Back Pain (CLBP)United States
-
Saint Francis HospitalAbbott Medical DevicesRecruitingChronic Low Back Pain (CLBP)United States
-
Charles University, Czech RepublicThe Jerzy Kukuczka Academy of Physical Education in KatowiceNot yet recruiting
-
Jaseng Medical FoundationRecruitingChronic Low Back Pain (CLBP)South Korea
-
Edward Via Virginia College of Osteopathic MedicineRecruitingChronic Low Back Pain (CLBP)United States
-
Cairo UniversityRecruitingChronic Low Back Pain (CLBP)Egypt
-
SRH Gesundheitszentrum Bad HerrenalbCompletedChronic Low Back Pain (CLBP)Germany
-
Cairo UniversityCompletedChronic Low-back Pain (cLBP)Egypt
-
Universitat Jaume IHospital Vall d'Hebron; Villa Beretta Rehabilitation Research innovation Institute and other collaboratorsNot yet recruitingChronic Low Back Pain (CLBP)
Clinical Trials on Virtual reality based high intensity interval training (VR-HIIT) group
-
University of ValenciaNot yet recruitingHealth Adult Subjects | Acute Effects of Exercise in Healthy PeopleSpain
-
Halmstad UniversityRecruitingAxial SpondyloarthritisSweden
-
University Hospital, GenevaCompletedMuscle Weakness | Gait, UnsteadySwitzerland
-
Wroclaw University of Health and Sport SciencesActive, not recruitingPhysical Activity | Blood Pressure | Cardiorespiratory Fitness | Adipose Tissue | AdolescentsPoland
-
Université de SherbrookeRecruiting
-
University of NottinghamActive, not recruiting
-
Centre Hospitalier Universitaire VaudoisRecruitingPeripheral Arterial DiseaseSwitzerland
-
Mayo ClinicActive, not recruitingCardiac RehabilitationUnited States
-
Karolinska University HospitalKarolinska InstitutetUnknownDermatomyositis | PolymyositisSweden
-
Wu JiarunCompletedBurnout,Motivation,Stress,Mental ToughnessMalaysia